Page 13«..10..12131415..2030..»

Pondering the parlance of the pandemic – Las Vegas Review-Journal

§ June 21st, 2020 § Filed under Nano Medicine Comments Off on Pondering the parlance of the pandemic – Las Vegas Review-Journal

Writers are word watchers.

Theyre the basic tools of our trade. We track their development like carpenters and plumbers monitor improvements in hammers and pipe wrenches.

They dont call us wordsmiths for nothing.

New words and phrases are coined constantly. Some have incredibly long shelf lives, others the life expectancy of a spring flower.

I mean, why is cool still, well, cool, and groovy not so much?

Not long ago, I was on a rural drive with my Chinese-born wife. We spotted two yokels perched on a sagging porch.

My wife turned to me. She wanted to use a phrase shed heard somewhere: country bumpkin.

Merriam-Webster defines bumpkin as an awkward and unsophisticated rustic. Its first usage was in 1570, from the Dutch boomken, a diminutive of boom tree. The word assumed its present meaning in 1613.

To my mind, it needed to be retired, or updated.

And my wife did just that as she pointed out the window: Look at those two country pumpkins.

That day, in my personal vocabulary, one phrase died and another was born.

It was a thing of beauty.

Social media jokes were immediate

These days, COVID-19 is changing the language of social health.

New words and phrases come at us every day. Sometimes old ones assume a stark new urgency. How innocent we were when we first heard that word: coronavirus.

Most of us knew what a virus was, but this was a new spin on an old microscopic nightmare. The social media jokes were immediate. There were ad nauseam jokes about a favorite Mexican beer. But this new threat was nothing you drank with a lime. It was a virus that had jumped from animals to humans, named for its menacing sunlike halo.

Many of us already knew the acronyms SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome). We knew about disease clusters and outbreaks, incubation and person-to-person disease spread. But this thing was crazier and more lethal.

We whispered the word coronavirus for a few days. Then it became the novel coronavirus because it had never been detected in humans before

Then we really got schooled.

Scientists gave it another name, SARS-CoV2, which in public usage quickly morphed into COVID-19, the respiratory disease caused by SARS-CoV2.

Confused yet?

No more hugs and kisses

So we adjusted and quickly. Nobody wanted to be considered any kind of corona pumpkin.

Soon, there were more technical words and phrases the kind that might be used at the latest World Health Organization conference.

As we watched the virus spread from China to Europe, we learned the difference between an epidemic and a pandemic. We learned about self-isolation. About using separate towels, sleeping alone and forgoing hugs and kisses.

We learned that close contact is being within 6 feet of a COVID-19 patient for a prolonged period.

Then came social distancing, avoiding face-to-face contact at the park and grocery store.

That concept quickly was tweaked to physical distancing because, while we minded the physical distances between us, we had to remain social.

Newspaper readers quickly were able to distinguish between a quarantine and a lockdown.

Cruise ships became associated with isolation and death.

We began bandying about phrases such as asymptomatic and public health crisis, as we would last nights baseball scores.

We were reminded all too quickly how a vaccine given to a healthy person to keep him or her from getting infected differed from an anti-viral, a medicine given to a person already infected.

We learned that remdesivir is an investigational anti-viral drug given to people in clinical trials and hoped it could put an end to this madness.

Our newest weapon in viral WWIII

The initial drip of scary new words turned into a flood. There was the index case the first documented case of an infectious disease. And there was patient zero, the moniker for the first person to become sick, and community spread, the passing of a contagious disease to individuals in a particular location who have no known contact with others infected.

And, by all means, beware of the super-spreader, who unknowingly transmits a communicable disease.

Along with the new words, old ones were given new context.

Words such as hoarding and selfish and panic-buying.

We now know that essential businesses are those that provide products to keep us fed and healthy. And people who never worked in construction or in a hospital now know the phrase N95 respirator.

New abbreviations have sprung up, such as PPE, which by now everyone in the U.S. knows is short for personal protective equipment.

We paid attention to fatality rates and the sinister-sounding R-naught, or R0, a virus reproductive number, a metric used to describe how contagious an infectious agent is.

We developed several new disease-fighting battle cries. We learned that a curve is the theoretical number researchers use to predict how many people will contract COVID-19 over a period of time. Then came flattening the curve, which means doing what we can to slow an outbreaks spread and crush the rising line on a chart.

Weve heard of contact tracing, our newest weapon in this viral World War III a way of identifying and monitoring those who may have had contact with an infectious person to halt COVID-19s spread.

And now we all talk about Zoom, a videoconferencing company, whose name has suddenly become a verb for real-time chats with friends and relatives, and which is on its way to reaching google status as a mainstream phrase.

A new definition for bravery

While these words were unknown to most of the world just a few months ago, we now use them daily.

We can survive this if we put into practice words weve known all our lives. Words such as compassion, caring and hope.

Whatever happens, there will be a new definition for the word bravery, and it will be applied in places that seemed unlikely not so long ago. Places such as hospital acute care centers, grocery stores and package delivery trucks.

It will be used to describe all who have helped maintain the comforting rhythms of everyday life, amid all the ugliness.

But may the rest of those phrases die quickly. Like groovy.

Now, that, my friends, is truly something beautiful.

See the rest here:
Pondering the parlance of the pandemic - Las Vegas Review-Journal

Read the Rest...

COVID-19 Shatters Calcium Ferrous Citrate Market as Key Players Forced to Halt Their Operations – Personal Injury Bureau UK

§ June 21st, 2020 § Filed under Nano Medicine Comments Off on COVID-19 Shatters Calcium Ferrous Citrate Market as Key Players Forced to Halt Their Operations – Personal Injury Bureau UK

The report on the Calcium Ferrous Citrate market provides a birds eye view of the current proceeding within the Calcium Ferrous Citrate market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Calcium Ferrous Citrate market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Calcium Ferrous Citrate market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

The Calcium Ferrous Citrate market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Calcium Ferrous Citrate market and the trends that will prevail in this industry.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @

What pointers are covered in the Calcium Ferrous Citrate market research study?

The Calcium Ferrous Citrate market report Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Calcium Ferrous Citrate market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Calcium Ferrous Citrate market report Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Natural Synthetic

Segment by Application Dietary Supplement Medicine Cosmetics

Global Calcium Ferrous Citrate Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Calcium Ferrous Citrate market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Calcium Ferrous Citrate Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include Global Calcium, Mitsubishi Chemical, Jost Chemical, Global Green Creations, Manus Aktteva Biopharma, Ferro Chem Industries, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Calcium Ferrous Citrate market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Calcium Ferrous Citrate market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The Calcium Ferrous Citrate market report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

You can Buy This Report from Here @

Some of the Major Highlights of TOC covers:

COVID-19 Shatters Calcium Ferrous Citrate Market as Key Players Forced to Halt Their Operations - Personal Injury Bureau UK

Read the Rest...

This Is What the Worlds Most Powerful Quantum Computer Looks Like – Barron’s

§ June 20th, 2020 § Filed under Quantum Computer Comments Off on This Is What the Worlds Most Powerful Quantum Computer Looks Like – Barron’s

Honeywell International announced Thursday that it has created the worlds most powerful quantum computer. And some of the things quantum computers can do are truly strange.

With a quantum volume of 64 the Honeywell quantum computer is twice as powerful as the next alternative in the industry, reads a blog post on the companys website.

A 64-volume quantum computer sounds amazing. But what is it? It means software-industrial conglomerate Honeywell (ticker: HON) has tethered together six high-functioning q-bits, or quantum bits.

OK, amazing. But who should care? The short answer is everyone.

Its tough to find an area of human activity where [quantum computing] wont help, Christopher Savoie, CEO of Zapata Computing, tells Barrons.

Quantum computing is still in its infancy, and the science is daunting, to say the least, but Savoie has a useful analogy. The Wright brothers took their flight in 1903, and by 1918 we had global air forces, he says. Honeywell is months past the Wright brothers in terms of quantum computing development, according to Savoie.

Quantum computers are, essentially, way more powerful computers. Problems which would might take days, weeks, or years to solve on a traditional computer can take minutes on a quantum computer.

Climate change, drug discovery, logistics, notes Savoie, right now you are limited by the number of variable your computer can handle. Quantum-computing speed grows exponentially. There is a hockey-stick graphic look in computing power as new q-bits get added to the system.

Honeywell stock doesnt trade on quantum fundamentals yet. Shares are down about 16% year to date, worse than the comparable drops of the S&P 500 and Dow Jones Industrial Average. Honeywell is a large aerospace supplier, and the commercial aviation business has been hammered by Covid-19. Boeing (BA) stock, for instance, is off more than 40% year to date.

Honeywell stock is flat in early Friday trading. The S&P is up about 0.8%.

The quantum-computing industry hasnt yet arrived, despite todays announcement. But quantum computers are already better than regular computers in certain instances. Google parent Alphabet (GOOGL) demonstrated the ability of its rudimentary quantum computer to beat traditional systems.

Our quantum computing starts with having a MEMS layer that acts to trap individual ytterbium atoms. We take atoms and hit them with a laser, which strips an electron and traps an ion in an electric field, Tony Uttley, president of Honeywell Quantum Solutions, told Barrons a few months ago, when the company embarked on its quest to make the most powerful computer. The ion is the q-bit. The cool thing about quantum mechanics is a q-bit can be a one or a zero at the same time.

The explanation of the quantum-computing hardware is nearly incomprehensible to most people. And the analogy between the quantum world and the regular world breaks down eventually. Its totally different tech. Quantum computers arent faster just because of the dual nature of a q-bit. They are also faster because of quantum entanglement and constructive interference.

Readers might have to Google both terms, but Uttley tried to help Barrons understand. With constructive interference, only the correct answer survives, he says. The system filters out the wrong answers.

Ask a question and receive only the correct answer. Quantum computers are always right? That situation feels almost religious, like querying God.

What constructive interference really means is the quantum computer solves a maze like a human does, says Savoie. Looking from overhead and tossing out obvious wrong paths before it even starts. That helps a little, but all the explanations help to drive home the idea that quantum-computing technology is a game-changer.

For Honeywell, its a business opportunity. It can create the hardware and join with business such as Zapata to build quantum software and data-analytic platforms.

Zapata is, essentially, an enterprise software company. Businesses arent likely to hire their own quantum programmers, but now they have someone to call to help with the toughest analytical problems.

It would be hard for each company to build their own quantum-computing department, though some banks are doing that already. Quantum programmers? reflects Uttley. The people who know how to program are called theorists, they are a combination of physicists and mathematician, and there are hundreds in the world, not thousands.

Thats one reason why between Honeywell and its partners, which include Microsoft (MSFT), are building a QaaS, or Quantum as a Service, business model.

Write to Al Root at

Read more:

This Is What the Worlds Most Powerful Quantum Computer Looks Like - Barron's

Read the Rest...

Honeywell Says It Has Built The Worlds Most Powerful Quantum Computer – Forbes

§ June 20th, 2020 § Filed under Quantum Computer Comments Off on Honeywell Says It Has Built The Worlds Most Powerful Quantum Computer – Forbes

Honeywell says its new quantum computer is twice as fast than any other machine.

In the race to the future of quantum computing, Honeywell has just secured a fresh lead.

The North Carolina-based conglomerate announced Thursday that it has produced the worlds fastest quantum computer, at least twice as powerful as the existing computers operated by IBM and Google.

The machine, located in a 1,500-square-foot high-security storage facility in Boulder, Colorado, consists of a stainless steel chamber about the size of basketball that is cooled by liquid helium at a temperature just above absolute zero, the point at which atoms stop vibrating. Within that chamber, individual atoms floating above a computer chip are targeted with lasers to perform calculations.

While people have studied the potential of quantum computing for decades, that is, building machines with the ability to complete calculations beyond the limits of classic computers and supercomputers, the sector has until recently been limited to the intrigue of research groups at tech companies such as IBM and Google.

But in the past year, the race between those companies to claim supremacy and provide a commercial use in the quantum race has become heated. Honeywells machine has achieved a Quantum Volume of 64, a metric devised by IBM that measures the capability of the machine and error rates, but is also difficult to decipher (and as quantum computing expert Scott Aaronson wrote in March, is potentially possible to game). By comparison, IBM announced in January that it had achieved a Quantum Volume of 32 with its newest machine, Raleigh.

Google has also spent significant resources on developing its quantum capabilities and In October said it had developed a machine that completed a calculation that would have taken a supercomputer 10,000 years to process in just 200 seconds. (IBM disputed Googles claim, saying the calculation would have taken only 2.5 days to complete.)

Honeywell has been working toward this goal for the past decade when it began developing the technology to produce cryogenics and laser tools. In the past five years, the company assembled a team of more than 100 technologists entirely dedicated to building the machine, and in March, Honeywell announced it would be within three months a goal it was able to meet even as the Covid-19 turned its workforce upside down and forced some employees to work remotely. We had to completely redesign how we work in the facilities, had to limit who was coming on the site, and put in place physical barriers, says Tony Uttley, president of Honeywell Quantum Solutions. All of that happened at the same time we were planning on being on this race.

The advancement also means that Honeywell is opening its computer to companies looking to execute their own unimaginably large calculations a service that can cost about $10,000 an hour, says Uttley. While it wont disclose how many customers it has, Honeywell did say that it has a contract with JPMorgan Chase, which has its own quantum experts who will use its machine to execute gargantuan tasks, such as building fraud detection models. For those companies without in-house quantum experts, queries can be made through intermediary quantum firms, Zapata Computing and Cambridge Quantum Computing.

With greater access to the technology, Uttley says, quantum computers are nearing the point where they have graduated from an item of fascination to being used to solve problems like climate change and pharmaceutical development. Going forward, Uttley says Honeywell plans to increase the Quantum Volume of its machine by a factor of 10 every year for the next five years, reaching a figure of 640,000 a capability far beyond that imagined ever before.

Go here to see the original:

Honeywell Says It Has Built The Worlds Most Powerful Quantum Computer - Forbes

Read the Rest...

This Is the First Universal Language for Quantum Computers – Popular Mechanics

§ June 20th, 2020 § Filed under Quantum Computer Comments Off on This Is the First Universal Language for Quantum Computers – Popular Mechanics

Przemyslaw Klos / EyeEmGetty Images

A quantum computing startup called Quantum Machines has released a new programming language called QUA. The language runs on the startups proprietary Quantum Orchestration Platform.

Quantum Machines says its goal is to complete the stack that includes quantum computing at the very bottom-most level. Yes, those physical interactions between quantum bits (qubits) are what set quantum computers apart from traditional hardwarebut you still need the rest of the hardware that will turn physical interactions into something that will run software.

Hot Qubits Lead to Quantum Computing Breakthrough

And, of course, you need the software, too. Thats where QUA comes in.

The transition from having just specific circuitsphysical circuits for specific algorithmsto the stage at which the system is programmable is the dramatic point, CEO Itavar Siman told Tech Crunch. Basically, you have a software abstraction layer and then, you get to the era of software and everything accelerated.

The language Quantum Machine describes in its materials isnt what you think of when you imagine programming, unless youre a machine language coder. Whats machine language? Thats the lowest possible level of code, where the instructions arent in natural or human language and are instead in tiny bits of direct instruction for the hardware itself.

The Government Is Desperate for COBOL Programmers

Coder Ben Eater made a great video that walks you through a sample program written in C, which is a higher and more abstract language, and how that information translates all the way down into machine code. (Essentially, everything gets much messier and much less readable to the human eye.)

This content is imported from YouTube. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

Machine code acts as a reminder that, on a fundamental level, everything inside your computer is passing nano-Morse code back and forth to do everything you see on the screen as well as all the behind the scenes routines and coordination. Since quantum computers have a brand new paradigm for the idea of hardware itself, theres an opening for a new machine code.

Quantum Machines seems to want to build the entire quantum system, from hardware to all the software to control and highlight it. And if that sounds overly proprietary or like some unfair version of how to develop new technology, we have some bad news for you about the home PC wars of the 1980s or the market share Microsoft Windows still holds among operating systems.

By offering a package deal with something for everyone when quantum computing isnt even a twinkle in the eye of the average consumer, Quantum Machines could be making inroads that will keep it ahead for decades. A universal language, indeed.

QUA is what we believe the first candidate to become what we define as the quantum computing software abstraction layer, Sivan told TechCrunch. In 20 years, we might look back on QUA the way todays users view DOS.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at

This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.

Read the original post:

This Is the First Universal Language for Quantum Computers - Popular Mechanics

Read the Rest...

Honeywell announces the creation of worlds highest performing quantum computer – Inceptive Mind

§ June 20th, 2020 § Filed under Quantum Computer Comments Off on Honeywell announces the creation of worlds highest performing quantum computer – Inceptive Mind

Honeywell has announced the creation of the worlds highest-performing quantum computing system. With a quantum volume of 64, the Honeywell quantum computer is twice as powerful as the next alternative in the industry.

What makes our quantum computers so powerful is having the highest quality qubits, with the lowest error rates. This is a combination of using identical, fully connected qubits and precision control, said Tony Uttley, president of Honeywell Quantum Solutions.

The core of the Honeywell system is an ultra-high vacuum chamber, which is a stainless steel sphere, about the size of a basketball. It has portals to allow in laser light, and from which the air has been pumped out such that it contains a vacuum of five times less particles than outer space. The chamber is cryogenically cooled to the temperature slightly above absolute zero (-262.7 C).

Inside the chamber are ion traps, each of which is the size of a coin of 25 US cents (24.3 mm). The ion plays the role of a qubit, and it is controlled by a laser, which is aimed at trapping the charge from outside the sphere through a small glass window. Within the chamber, electric fields levitate individual atoms 0.1 mm above an ion trap, a silicon chip covered in gold about the size of a quarter. Scientists shine lasers at these positively charged atoms to perform quantum operations.

For the context of how small an atom is, if you cup your hands into a sphere, youre holding about a trillion trillion atoms, Tony said.

According to the company, the main focus while building the quantum computer was on eliminating the errors present within the system on smaller numbers of qubits and then working to scale up the number of qubits. Low errors in the quantum operations expand the quantum volume, ultimately increasing the capability of quantum computing.

The Honeywell quantum computer has already been tested by JPMorgan Chase, one of the largest financial institutions, which has its own quantum experts. In addition to JPMorgan Chase, other customers whose names the company does not disclose are testing the new Honeywell system. According to Honeywell, these are companies and organizations that are related to chemistry, materials science, machine learning, and optimization. Later this year, Honeywell, along with Microsoft, will provide access to the new quantum computer through the Microsoft Azure cloud.

Read more:

Honeywell announces the creation of worlds highest performing quantum computer - Inceptive Mind

Read the Rest...

Quantum Cryptography Market to Witness over XX% Growth ‘in Revenue During the COVID-19 Pandemic Cole Reports – Cole of Duty

§ June 20th, 2020 § Filed under Quantum Computer Comments Off on Quantum Cryptography Market to Witness over XX% Growth ‘in Revenue During the COVID-19 Pandemic Cole Reports – Cole of Duty


Quantum cryptography is a new method for secret communications that provides the assurance of security of digital data. Quantum cryptography is primarily based on the usage of individual particles/waves of light (photon) and their essential quantum properties for the development of an unbreakable cryptosystem, primarily because it is impossible to measure the quantum state of any system without disturbing that system.

Request For Report [emailprotected]

It is hypothetically possible that other particles could be used, but photons offer all the necessary qualities needed, the their behavior is comparatively understandable, and they are the information carriers in optical fiber cables, the most promising medium for very high-bandwidth communications.

Quantum computing majorly focuses on the growing computer technology that is built on the platform of quantum theory which provides the description about the nature and behavior of energy and matter at quantum level. The fame of quantum mechanics in cryptography is growing because they are being used extensively in the encryption of information. Quantum cryptography allows the transmission of the most critical data at the most secured level, which in turn, propels the growth of the quantum computing market. Quantum computing has got a huge array of applications.

Market Analysis:

According to Infoholic Research, the Global Quantum cryptography Market is expected to reach $1.53 billion by 2023, growing at a CAGR of around 26.13% during the forecast period. The market is experiencing growth due to the increase in the data security and privacy concerns. In addition, with the growth in the adoption of cloud storage and computing technologies is driving the market forward. However, low customer awareness about quantum cryptography is hindering the market growth. The rising demands for security solutions across different verticals is expected to create lucrative opportunities for the market.

Market Segmentation Analysis:

The report provides a wide-ranging evaluation of the market. It provides in-depth qualitative insights, historical data, and supportable projections and assumptions about the market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendors portfolio, blogs, whitepapers, and vendor presentations. Thus, the research report serves every side of the market and is segmented based on regional markets, type, applications, and end-users.

Countries and Vertical Analysis:

The report contains an in-depth analysis of the vendor profiles, which include financial health, business units, key business priorities, SWOT, strategy, and views; and competitive landscape. The prominent vendors covered in the report include ID Quantique, MagiQ Technologies, Nucrypt, Infineon Technologies, Qutools, QuintenssenceLabs, Crypta Labs, PQ Solutions, and Qubitekk and others. The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant investments in R&D.

Get Complete TOC with Tables and [emailprotected]

Competitive Analysis

The report covers and analyzes the global intelligent apps market. Various strategies, such as joint ventures, partnerships,collaborations, and contracts, have been considered. In addition, as customers are in search of better solutions, there is expected to be a rising number of strategic partnerships for better product development. There is likely to be an increase in the number of mergers, acquisitions, and strategic partnerships during the forecast period.

Companies such as Nucrypt, Crypta Labs, Qutools, and Magiq Technologies are the key players in the global Quantum Cryptography market. Nucrypt has developed technologies for emerging applications in metrology and communication. The company has also produced and manufactured electronic and optical pulsers. In addition, Crypta Labs deals in application security for devices. The company deals in Quantum Random Number Generator products and solutions and Internet of Things (IoT). The major sectors the company is looking at are transport, military and medical.

The report includes the complete insight of the industry, and aims to provide an opportunity for the emerging and established players to understand the market trends, current scenario, initiatives taken by the government, and the latest technologies related to the market. In addition, it helps the venture capitalists in understanding the companies better and to take informed decisions.

Regional Analysis

The Americas held the largest chunk of market share in 2017 and is expected to dominate the quantum cryptography market during the forecast period. The region has always been a hub for high investments in research and development (R&D) activities, thus contributing to the development of new technologies. The growing concerns for the security of IT infrastructure and complex data in America have directed the enterprises in this region to adopt quantum cryptography and reliable authentication solutions.

<<< Get COVID-19 Report Analysis >>>


The report provides an in-depth analysis of the global intelligent apps market aiming to reduce the time to market the products and services, reduce operational cost, improve accuracy, and operational performance. With the help of quantum cryptography, various organizations can secure their crucial information, and increase productivity and efficiency. In addition, the solutions are proven to be reliable and improve scalability. The report discusses the types, applications, and regions related to this market. Further, the report provides details about the major challenges impacting the market growth.

Read the original here:

Quantum Cryptography Market to Witness over XX% Growth 'in Revenue During the COVID-19 Pandemic Cole Reports - Cole of Duty

Read the Rest...

Being happy can protect you from gastrointestinal distress – The New Indian Express

§ June 20th, 2020 § Filed under Genetically Modified Humans Comments Off on Being happy can protect you from gastrointestinal distress – The New Indian Express


NEW YORK: Researchers have found that Serotonin, a chemical known for encouraging happiness and well-being, can reduce the ability of some intestinal pathogens to cause deadly infections.

The findings, publishing in the journal Cell Host & Microbe, could offer a new way to fight infections for which few truly effective treatments currently exist.

"Although the vast majority of research on serotonin has centred on its effects in the brain, about 90 per cent of this neurotransmitter - a chemical that nerve cells use to communicate with each other - is produced in the gastrointestinal tract, study lead author Vanessa Sperandio from UT Southwestern Medical Centre in the US, explained.

In humans, trillions of bacteria live within this space. Most of these gut bacteria are beneficial, but pathogenic bacteria can also colonize the gastrointestinal tract, causing serious and potentially fatal infections.

Because gut bacteria are significantly affected by their environment, the research team wondered whether the serotonin produced in the gut can affect the virulence of pathogenic bacteria that infect the gastrointestinal tract.

They worked with Escherichia coli O157, a species of bacteria that causes periodic outbreaks of often deadly foodborne infection.

The team grew these pathogenic bacteria in Petri dishes in the lab, then exposed them to serotonin.

Gene expression tests showed that serotonin significantly reduced the expression of a group of genes that these bacteria use to cause infections.

Additional experiments using human cells showed that the bacteria could no longer cause infection-associated lesions on the cells if these bacteria were exposed to serotonin.

Next, the researchers examined how serotonin affected virulence in living hosts.

Using mice, the researchers studied how serotonin might change the ability for Citrobacter rodentium - a mouse gut bacterium often used as an analog for E. coli in humans - to infect and sicken their hosts.

These mice were genetically modified to either over- or underproduce serotonin in their gastrointestinal tracts.

Those that overproduced this neurotransmitter were less likely to become colonised by C. rodentium after being exposed to this bacterium or had relatively minor courses of illness, according to the study

Treating mice with fluoxetine (sold under the brand name Prozac) to increase serotonin levels prevented them from getting sick from C. rodentium exposure.

However, the mice that underproduced serotonin became much sicker after bacterial exposure, often dying from their illness.

In the future, the research team plan to study the feasibility of manipulating serotonin levels as a way of fighting bacterial infections in the gastrointestinal tract.

Visit link:

Being happy can protect you from gastrointestinal distress - The New Indian Express

Read the Rest...

Rising out of the crisis: Where to find new markets and customers – VentureBeat

§ June 20th, 2020 § Filed under Nanotech Comments Off on Rising out of the crisis: Where to find new markets and customers – VentureBeat

The pandemic has upended the business models of most startups and existing companies. As the economy reopens, companies are finding that customers may have disappeared or that their spending behavior has changed. Suppliers are going out of business or requiring cash-up-front terms. Accounts receivables are stretching way out. Revenue models and forecasts are no longer valid.

In sum, whatever business model you had at the beginning of the year may be obsolete.

While theres agreement that companies need to adapt to changing markets and rapidly find new markets, new customers, and new revenue models, the question is how? What tools and methods can a C-suite team use to do so?

While lean startups are built with Business Model Canvas, Customer Development, and Agile Engineering, theres an additional tool the Market Opportunity Navigator that can help entrepreneurs discover new opportunities.

Heres how.

When COVID-19 first emerged, established companies rapidly pivoted. Some focused on remote work, others offered new ways to learn online. Swiss smart flooring startup Technis now helps supermarkets regulate the flow of shoppers. Large companies like GM, Ford, and Rolls-Royce began to produce ventilators. Companies in cosmetics and perfume production pivoted their production lines as well. With ethanol and glycerin on hand and equipment required to fill bottles, French luxury giant LVMH has started to produce sanitizer just like gin and whiskey distilleries across the US and UK have done.

Although the large firms made the headlines, startups also pivoted. For instance, Italian additive manufacturing startupIsinnova used its 3D-printing equipmentto produce a crucial valve for oxygen masks. New York-based startupKatena Oncology discovered that a cancer detection tool under development could be adapted to test for coronavirus.

In these examples CEOs instinctually figured out 1) their core, and 2) market needs where their competencies/abilities could be used.

Rather than running on instinct, theMarket Opportunity Navigator can help CEOs figure out their next moves in this confusing recovery. It can provide a big-picture perspective to find different potential markets for your companys competencies/abilities. This is the first step before you zoom in and design the business model, engage in focused customer development or,test your minimal viable products.

Take the example ofAbionic, a nanotech startup.

Abionics tests can detect allergies, cardiovascular diseases, sepsis, and other diseases in five minutes. As the pandemic hit, the companys leaders wondered how their tests could be used in the fight against COVID-19. Using the Market Opportunity Navigator, Abionic realized their test could diagnose sepsis up to 72 hours before a septic shock would occur in COVID-19 patients.

One of the worksheets below from the Market Opportunity Navigator provides a systematic view of Abionics market discovery process: The upper part of the worksheet shows Abionics technological assets, and the lower part shows how these abilities can be used different market opportunities.

By looking at their technological abilities, especially in the early detection of sepsis, and clinical data showing that septic shock is one of the key complications of a coronavirus infection, Abionic identified a new market opportunity to help patients suffering from COVID-19. Their CEO Nicolas Durand explains: If doctors are able to diagnose sepsis up to 72 hours before a septic shock would occur in COVID-19 patients, they can prescribe an antibiotic therapy much earlier, thereby potentially saving the lives of millions. In order to test this application of our technology, we deployed our machines at the Hospital at the University of Geneva and see promising results!

Abionic and other companies were able to act fast, as they already possessed technological abilities that, with limited adjustments, could be pivoted or repurposed to the newly identified COVID-19 opportunities.

Yet, because the crisis and recovery will create a new normal, additional opportunities will emerge that wait to be discovered by startups and existing companies. Think about looking beyond the immediate opportunities of existing customers and markets, and take a mid- to long-term view on how you can proactively identify new and emerging market opportunities. The three worksheets of theMarket Opportunity Navigatorhelp you to:

The COVID-19 crisis and recovery creates fundamental shifts in our economies and societies, and a new normal is emerging. Winners in this new normal will be able to quickly understand

The Market Opportunity Navigator is a framework for this identification process.

You can download the Market Opportunity Navigator and its free worksheetshere.

Steve Blankis a retired serial entrepreneur-turned-educator who created the Customer Development methodology that launched the lean startup movement, which he wrote about in his book,The Four Steps to the Epiphany.Blank teaches Lean LaunchPad classes at Stanford University and Columbia University where he is a senior fellow for entrepreneurship.

Read more:

Rising out of the crisis: Where to find new markets and customers - VentureBeat

Read the Rest...

Is China Threatening Americas Dominance In The Digital Space? – Forbes

§ June 20th, 2020 § Filed under Nanotech Comments Off on Is China Threatening Americas Dominance In The Digital Space? – Forbes

The Digital Silk Road is one of the flagship projects in China's Belt & Road Initiative

The Digital Silk Road

As one of Chinas grand proposals within the Belt and Road Initiative (BRI), the Digital Silk Road (DSR) project was introduced in March 2015.The DSR incorporates four interrelated, tech-focused components. First, China is investing resources into digital frameworks abroad, including fiber optic cable lines and data hubs. Secondly, the project focuses on creating cutting edge innovations - like satellite navigation systems and smart city projects - which will be fundamental in giving China an edge as a global economic and military power. China is working on rapidly expanding its area of DSR projects. In 2019, the Chinese government launched a new project called the "Belt and Road Digital Economy International Cooperation Initiative'' with a number of nations including the United Arab Emirates, Thailand, Turkey, Laos, Serbia, Kingdom of Saudi Arabia, and Egypt. The Chinese government also established cooperation agreements with 16 other countries to develop technology focused projects under the umbrella of the New Silk Road Initiative.

From a mid to long-term perspective, China plans to strategically fortify this digital initiative. In April of last year, a report published by the Office of the Leading Group for Promoting the Belt and Road Initiative highlighted that the Chinese Communist Party (CCP) has actively focused on the DSR Initiative with innovation-focused industrial frontier areas. These include cloud computing, nanotechnology, quantum computing, big data, artificial intelligence, and smart cities.

China has made significant telecom investments globally under its flagship Belt & Road Initiative

Impact of Covid-19

Covid-19 has significantly impacted the Chinese economy, particularly the small-medium enterprises. Thus, the governments fiscal and monetary policies have shifted focus on stabilizing the domestic economy. This has strongly impacted the BRI. However, the Information Communication Technology (ICT) infrastructure projects are more cost-effective and can be completed at a faster pace compared to transportation and energy projects. Therefore, the DSR projects are more likely to attract significant investment and garner more interest from investors as compared to other BRI projects after Covid-19.

Is the Digital Silk Road a challenge and a national security threat to the US?

Fitch Solutions believes that the race in technological advancements will continue to be a key focal point of tension between the US and China. The Digital Silk Road is an essential pillar of China's global infrastructure strategy to manage the flow of data worldwide. Most of the infrastructure that is being used within the DSR projects involves little if any US technology, which is a cause of major concern for many Western policymakers and business executives. This is compounded by the fact that data traffic monitoring within China has greatly increased and thus the potential interference with sensitive monetary and security-related data could also be significantly compromised. Chinese tech firms have become highly proficient at using artificial intelligence (AI) to strengthen both their local businesses and relationships with consumers. The data and information accumulated from end-users will give Chinese companies considerably greater insights which will ultimately help them in gaining substantial market share within the BRI countries.

The Belt and Road Initiative supported by the DSR projects do not come without criticism and controversy. Critics have claimed that many Southeast Asian countries involved in the BRI have been drawn in by China's rigorous laws on the localization of data. However, some analysts argue that such changes are mostly being made to protect the information of citizens and incentivize foreign investments into local data hubs, rather than an inclination for ascribing to China's model of cyber administration. Nonetheless, the potential for these structures to be utilized by local governments to clamp down on social discord and political opponents cannot be ignored.

Smart City, Guangzhou Urban Skyline

The BRI has advanced Chinas technological prowess to the point where it now poses as the quintessential challenger to the US in terms of global technological partnerships. Earlier this year in February, the CCP made a concerted effort to focus on digital infrastructure projects including 5G expansions as one of the critical solutions to bolster their economy after the Covid-19 pandemic. Chinese companies such as Huawei Marine Networks have already laid down about 36,964 miles of undersea fibre optic cables in more than 95 different projects spanning the Indo-Pacific, South Pacific, and the Atlantic oceans. Chinese firms' global share in such transnational undersea cable projects have skyrocketed from a mere 7% in 2012 to 20% in 2019.

Expected market growth of 5G subscribers globally.

What choice will the US make?

American business leaders and the Trump administration are clearly intent on protecting US companies and supply chains from heavy reliance on China. For example, the Semiconductor Industry Association (SIA)s recent $32B proposal aims to sharpen the edge of the US semiconductor industry. Semiconductor chips underpin some of the critical commercial and defense technologies of the future which include 5G networks and artificial intelligence. Furthermore, US Justice Department officials tacit pressure on a high-capacity undersea data cable system to bypass Hong Kong is a clear example that reflects Americas hardening stance on China.

In the Covid-19 era and especially given the acrimonious sentiment in Washington and Beijing with respect to Sino-US relations, it is incumbent to not forget that competition and cooperation have always defined US-China relations. The United States is currently losing the race against China in the digital space. However, that does not mean the race is over. Public-private partnerships are needed now more than ever. The US government and the private sector must invest significantly more resources into developing technology and advancing innovation at home. Failing to do so could risk the US permanently losing its global technological leadership to China.

A special thanks to Jeeho Bae and Yaser Faheem for contributing to this article.


Mr. Earl Carr is the Vice President of International Research at Momentum Advisors, a New York based SEC-registered international wealth management firm. Jeeho Bae and Yaser Faheem are Research Consultants at Momentum Advisors.

See more here:

Is China Threatening Americas Dominance In The Digital Space? - Forbes

Read the Rest...

Halo Labs Announced Edibles Expansion in California and Oregon – Business Wire

§ June 20th, 2020 § Filed under Nanotech Comments Off on Halo Labs Announced Edibles Expansion in California and Oregon – Business Wire

TORONTO--(BUSINESS WIRE)--Halo Labs is pleased to announce an update on the Companys edibles product launch and expansion plan in California and Oregon to capitalize on segment growth. According to BDS Analytics, edibles spending in the US and Canada is forecast to grow to more than $4.1 billion by 2022. In California, ingestibles generated $44 million in sales in April 2020, 3 percent growth when compared to April 2019. In Oregon, ingestibles generated $12.5 million in sales in April 2020 and represents 18 percent growth from April 2019.


In California, Jeff Stewart founder of Outergalactic Chocolates, is leading Halos ingestibles product launches in California. Since launching in 2017, their colorful line of milk, dark, and sugar-free chocolates have been recognized as, Best Dark Chocolate Hybrid, and Best Chocolate Truffle by Edibles Magazine. OGC also took home the prize for Best Chocolate at the Emerald Cup in 2017. Resident of Mendocino County and a cannabis farmer since 1982, Jeff Stewart is the former owner of The Chief Smokehouse (now known as The Big Chief) on Highway 101 in Laytonville, California in heart of the Emerald Triangle.

Kiran Sidhu, CEO and Co-founder of Halo Labs stated, We plan to launch sales in California by Q3 2020 with 10 different gummy packages under the Hush brand. The gummies will be vegan, gluten free, and feature organic ingredients. Variety in selection is critical to capturing the hearts and minds of consumers. Therefore, in addition to delivering value at a target out the door price of $15 and $18 on 10 piece and 20 configurations, we also are offering a nanotechnology format for quicker absorption in numerous flavors. We aim to offer the best value proposition bar none to the California consumer.

The Company intends to launch strain specific formulations in sativa, indica and hybrid. Halo plans to manufacture under Halos Type N license in Ukiah and roll out up to 36 different configurations in California. Total capacity per day in Ukiah is 1,125 bags or 11,250 gummies per day assuming a 10 piece configuration. Additional edible products will include Hush elixirs that are vegan, gluten free, with no added glycerin or sugar.


BDS Analytics found that the ingestibles product category is growing at a faster rate in Oregon than in California. Hush currently sits in the Top 10 edibles brands in the state. The Company believes expanding upon its current single piece 50 mg THC gummy and single piece 100mg 1:1 gummy will help garner market share. New configurations include a smaller single 50 mg piece, and 5 and 10 piece multipacks in 10mg and 5mg THC strength as well as a microdose line of 20 pieces in 2.5 mg THC strength. The Company is actively expanding gummy production by adding kitchen capacity onsite in Medford, Oregon as well as expanding contract manufacturing relationships.

Mr. Sidhu continued, In Oregon we have been producing about 50,000 gummies per month with a third party kitchen. By building out our own capacity and expanding to additional third party suppliers, we anticipate at least doubling, if not tripling production by the end of Q3.

Building on the California formulations anticipated success, new gummy SKUs in Oregon will also be vegan and gluten free. The Company will expand the Hush Sizzurp line up as well to include a marionberry flavor in THC and THC/CBD 1:1 formulations for a total of twelve offerings. These elixirs will also be free from added glycerin or sugar.

By expanding the edibles product set, the Company anticipates garnering up to five percent market share in California and up to twenty percent market share in Oregon. This represents $600,000 and $500,000 in incremental monthly gummy business respectively for a total target of $1.1 million per month.

Mr. Sidhu concluded, Having our own kitchens and oil manufacturing enable us to capture more margin and be aggressive with price. We plan to offer the most delicious gummies and elixirs at the best value to delight cannabis consumers in our core markets.

About Halo

Halo is a leading cannabis cultivation, manufacturing, and distribution company that grows and extracts and processes quality cannabis flower, oils, and concentrates and has sold over 5 million grams of oils and concentrates since inception. Additionally, Halo has continued to evolve its business through delivering value with its products and now via verticalization in key markets in the United States and Africa with planned expansion into European and Canadian markets. With a consumer-centric focus, Halo markets innovative, branded, and private label products across multiple product categories.

Recently, the Company entered into binding agreements to acquire a dispensary in Los Angeles, 3 KushBar branded dispensaries, five development permits in Alberta Canada, and Canmart which holds wholesale distribution and special licenses allowing the import and distribution of cannabis based products for medicinal use (CBPMs) in the United Kingdom. Halo is led by a strong, diverse management team with deep industry knowledge and blue-chip experience. The Company is currently operating in the United States in California, Oregon, and Nevada while having an international presence in Lesotho within a planned 200+ hectare cultivation zone via Bophelo as well as planned importation and distribution in the United Kingdom via Canmart.

For further information regarding Halo, see Halos disclosure documents on SEDAR at

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halos beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halos control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but is not limited to, the Companys strategic tactics that will drive financial results in 2020, the success of new edibles products in California and Oregon, the ability of the Company's current working capital to meet its cash needs for fiscal 2020, and the ability of the Company to continue to build on its current market position.

By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements.

See original here:

Halo Labs Announced Edibles Expansion in California and Oregon - Business Wire

Read the Rest...

Carbon Nanotube Transparent Conductive Film Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Eikos, Unidym,…

§ June 20th, 2020 § Filed under Nanotech Comments Off on Carbon Nanotube Transparent Conductive Film Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Eikos, Unidym,…

Latest Carbon Nanotube Transparent Conductive Film Market report evaluates the impact of Covid-19 outbreak on the industry, involving potential opportunity and challenges, drivers and risks and market growth forecast based on different scenario. Global Carbon Nanotube Transparent Conductive Film industry Market Report is a professional and in-depth research report on the worlds major regional market.

This Carbon Nanotube Transparent Conductive Film Market report will help the business leaders to detail better field-tested strategies and settle on educated choices to improved benefit

Get Exclusive Sample of Report on Carbon Nanotube Transparent Conductive Film market is available at

Top Players Listed in the Carbon Nanotube Transparent Conductive Film Market Report areEikos, Unidym, Nanocyl, Cnano, SouthWest NanoTechnologies, Canatu, NanoIntegris, Toray, Shenzhen Nanotech Port Co. Ltd, Foxconn, Hanao Co., Ltd.

Carbon Nanotube Transparent Conductive Filmmarket report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market Segmentations: Global Carbon Nanotube Transparent Conductive Film market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer.

Based on type, report split into Single-Walled Nanotubes (SWNTs), Double Wall Nanotubes, Multi-Walled Nanotubes (MWNTs).

Based on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Touch Screens, Flexible Displays, Solar Cell, Other.

Download the Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies.

The report introduces Carbon Nanotube Transparent Conductive Film basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis. Insightful predictions for the Carbon Nanotube Transparent Conductive Film Market for the coming few years have also been included in the report.

In the end, Carbon Nanotube Transparent Conductive Filmreport provides details of competitive developments such as expansions, agreements, new product launches, and acquisitions in the market for forecasting, regional demand, and supply factor, investment, market dynamics including technical scenario, consumer behavior, and end-use industry trends and dynamics, capacity, spending were taken into consideration.

Important Key questions answered in Carbon Nanotube Transparent Conductive Filmmarket report:

Get Special Discount Up To 50%,

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Name: Rohan S. Email:[emailprotected] Phone: +1-909-329-2808 UK: +44 (203) 743 1898 Website:

Read more:

Carbon Nanotube Transparent Conductive Film Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Eikos, Unidym,...

Read the Rest...

Sixth Wave Announces Listing on the OTCQB – Yahoo Finance

§ June 19th, 2020 § Filed under Nanotechnology Comments Off on Sixth Wave Announces Listing on the OTCQB – Yahoo Finance

Halifax, Nova Scotia--(Newsfile Corp. - June 19, 2020) - Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB: ATURF) (FSE: AHUH) ("Sixth Wave" or the "Company") is pleased to announce that the Company has been approved to trade on the OTCQB Venture Market under the trading symbol "ATURF". Sixth Wave's common shares will continue to trade on the Canadian Securities Exchange under the symbol "SIXW".

The OTCQB Venture Market is designed for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. Graduating to the OTCQB Venture Market marks an important milestone for companies, enabling them to increase transparency and implement the technology and regulations to improve the information and trading experience for investors.

Dr. Jonathan Gluckman, Sixth Wave's President & CEO commented, "We are pleased to have met the qualifications for the OTCQB Venture Market and believe trading on the OTCQB will help increase liquidity and strengthen our shareholder base."

About Sixth Wave

Sixth Wave is a development stage nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers ("MIP's"). The Company is in the process of commercializing its AffinityTM cannabinoid purification system, as well as, IXOS, a line of extraction polymers for the gold mining industry.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for detection and separation of viruses, biogenic amines and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit our web site at:


"Jon Gluckman" Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company: Phone: (801) 582-0559 E-mail:

Cautionary Notes

All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.

To view the source version of this press release, please visit

Visit link:

Sixth Wave Announces Listing on the OTCQB - Yahoo Finance

Read the Rest...

COVID19 Impact- Global Nano Liquid Products Market Recent Industry Developments and Growth Strategies Adopted by Top Key Players Nanofixit,…

§ June 19th, 2020 § Filed under Nanotechnology Comments Off on COVID19 Impact- Global Nano Liquid Products Market Recent Industry Developments and Growth Strategies Adopted by Top Key Players Nanofixit,…

Global Nano Liquid Products Market: Trends Estimates High Demand by 2027

Nano Liquid Products Market report 2020, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Nano Liquid Products Market research Reports offers an extensive collection of reports on different markets covering crucial details. The report studies the competitive environment of the Nano Liquid Products Market is based on company profiles and their efforts on increasing product value and production.

Nano Liquid Products research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers, and challenges.

The final report will add the analysis of the Impact of Covid-19 in this report Nano Liquid Products industry.

Adapting to the recent novel COVID-19 pandemic, the impact of the COVID-19 pandemic on the global Nano Liquid Products market is included in the present report. The influence of the novel coronavirus pandemic on the growth of the Nano Liquid Products market is analyzed and depicted in the report.

Some of the companies competing in the Nano Liquid Products market are: Nanofixit, Liquidnano, Nasiol, Shenzhen Sunqt Technology, Ultimate Nanotechnology, and Nano Liquid Solutions

Get a Sample Copy of the [emailprotected]

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Nano Liquid Products Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and development plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Global Nano Liquid Products Market Research Report 2020 carries in-depth case studies on the various countries which are involved in the Nano Liquid Products market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Nano Liquid Products market report answer pertaining to the regional reach of the industry

The report claims to split the regional scope of the Nano Liquid Products market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present How does the sales scenario look for the future

Considering the present scenario, how much revenue will each region attain by the end of the forecast period

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

The scope of the Report:

The report segments the global Nano Liquid Products market on the basis of application, type, service, technology, and region. Each chapter under this segmentation allows readers to grasp the nitty-gritties of the market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the market. It also address political scenarios that are expected to impact the market in both small and big ways.The report on the global Nano Liquid Products market examines changing regulatory scenario to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Reasons for Read this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments


Chapter 1: Nano Liquid Products Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3: Nano Liquid Products Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Nano Liquid Products Market Effect Factors Analysis

Chapter 12: Global Nano Liquid Products Market Forecast to 2027

Get Discount @

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

Ph: +1-352-353-0818 (US)

Continue reading here:

COVID19 Impact- Global Nano Liquid Products Market Recent Industry Developments and Growth Strategies Adopted by Top Key Players Nanofixit,...

Read the Rest...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – WorldsTrend

§ June 19th, 2020 § Filed under Nano Medicine Comments Off on Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – WorldsTrend

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

Nanomedicine Market Drivers and Restrains: Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.


The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis: Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis: Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscape Major Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.


Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics Treatments Nanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological Diseases Nanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives Oncology Nanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East Africa Nanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.


Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at:

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage



Contact: +919607065656/ +919607195908

Go here to see the original:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - WorldsTrend

Read the Rest...

Nanomedical Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE – Cole of Duty

§ June 19th, 2020 § Filed under Nano Medicine Comments Off on Nanomedical Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE – Cole of Duty

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.

FYI, You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

The Nanomedical Market is expected to exceed more than US$ 306 Billion by 2024 at a CAGR of 10.3% in the given forecast period.

Browse Full Report:

Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.

Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.

Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.

The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.

The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Nanomedical Market has been segmented as below:

The Nanomedical Market is segmented on the lines of Nanomedical Market, By Indication, Nanomedical Market, By Application, Nanomedical Market, By Modality, Nanomedical Market, By Region and Nanomedical Market, By Company.

Nanomedical Market, By Indication this market is segmented on the basis of Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases and Others. Nanomedical Market, By Application this market is segmented on the basis of Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines and Others. Nanomedical Market, By Modality this market is segmented on the basis of Treatments and Diagnostics. Nanomedical Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Nanomedical Market, By Company this market is segmented on the basis of Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company and Sigma-Tau Pharmaceuticals, Inc.

The report covers:

Report Scope:

The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

Reasons to Buy this Report:

Request Sample Report from here:

Table of Contents:

Other Related Market Research Reports:

Biologic and Medical Imaging Reagents Market Overview and Share Forecasted to 2024 MRE Report

Hospital Supplies Market 2019 Perceive Substantial Growth During 2024 MRE Report


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [emailprotected]

Phone: +1-855-984-1862

Country: United States


Read more:
Nanomedical Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE - Cole of Duty

Read the Rest...

Nanobiotix Receives Feedback From US FDA to Advance Phase III Head and Neck Cancer Study Design and CMC Development Plan for NDA – Business Wire

§ June 19th, 2020 § Filed under Nano Medicine Comments Off on Nanobiotix Receives Feedback From US FDA to Advance Phase III Head and Neck Cancer Study Design and CMC Development Plan for NDA – Business Wire

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

With our recent Fast Track designation for NBTXR3 in this patient population, acceptance of the design of our pivotal phase III trial and agreement on our CMC plan, Nanobiotix is well positioned to deliver on our promise of serving the unmet needs of head and neck cancer patients. Our head and neck cancer pathway is our top priority and these developments represent critical milestones that will allow us to administer and supply our trial. We look forward to taking the necessary steps to initiate NANORAY-312 and evaluate the potential of NBTXR3 to improve treatment outcomes for patients around the world. Laurent Levy, CEO of Nanobiotix.

NANOBIOTIX (Euronext : NANO ISIN : FR0011341205 the Company) (Paris:NANO), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the FDA has provided necessary feedback regarding the design of NANORAY-312, the Companys pivotal phase III global registration trial in head and neck cancer. The FDA also agreed to the NBTXR3 chemistry, manufacturing, and controls (CMC) Development Plan to support the phase III trial and a future New Drug Application (NDA) for the product.

NANORAY-312: A Phase III Study of NBTXR3 Activated by Investigators Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-based Chemotherapy-ineligible Elderly Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

NANORAY-312 will be a phase III investigators choice, dual-arm, randomized (1:1) global registration trial including elderly head and neck cancer patients who are ineligible for platinum-based chemotherapy.

Patients in the control arm will receive radiation therapy with or without cetuximab (investigators choice), and patients in the treatment arm will receive NBTXR3 activated by radiation therapy with or without cetuximab (investigators choice).

The trial is expected to recruit approximately 500 patients. A futility analysis is expected 18 months after the first patient in the trial is randomized, and the interim analysis for progression-free survival (PFS) superiority is expected at 24-30 months. The final analysis will report on PFS and overall survival. Quality of Life will also be measured as a key secondary outcome. In the event of favorable data from the interim analysis, the FDA has advised that NBTXR3 could potentially qualify for accelerated approval.

In support of the phase III trial and a future NBTXR3 New Drug Application (NDA), Nanobiotix met with the FDA in a Type B end-of-phase I meeting on October 16, 2019. Following additional correspondence with the FDA, including written responses to the FDAs recommendations, the Company received written FDA guidance on April 3, 2020. The Company expects to commence NANORAY-312 after making protocol refinements and securing the requisite financing to fund the trial.

Agreement to CMC Development Plan

The FDAs written response regarding the CMC Development Plan does not raise any safety concerns for continued clinical development of NBTXR3, and the FDA agreed to the updated CMC Plan for NBTXR3 during an ongoing phase III clinical trial.


About NBTXR3 NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide standards of radiation care. The physical mode of action of NBTXR3 makes it applicable across solid tumors.

NBTXR3 is actively being evaluated in clinical trials worldwide as a potential treatment in various cancer indications. The Company is prioritizing the development of NBTXR3 in the United States and the EU for the treatment of patients with locally advanced head and neck cancers ineligible for chemotherapy.

Nanobiotix is also running an Immuno-Oncology development program, evaluating NBTXR3 activated by radiotherapy as a primer of immune response in combination with checkpoint inhibitors. The Company has launched a phase I clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 checkpoint inhibitors in patients with locoregional recurrent (LRR) or recurrent and metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) amenable to re-irradiation or with lung or liver metastasis (mets) from any primary cancer eligible for anti-PD-1 therapy.

Other ongoing NBTXR3 trials are treating patients with liver cancers (hepatocellular carcinoma and liver metastasis), locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and pancreatic cancer. The Company has a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (initially expected to support nine new clinical trials in the United States) to evaluate NBTXR3 across several cancer types.

About NANOBIOTIX: Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a US affiliate in Cambridge, MA, and European affiliates in France, Spain and Germany.


This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the universal registration document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.20-010 on May 12, 2020 (a copy of which is available on and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

View original post here:
Nanobiotix Receives Feedback From US FDA to Advance Phase III Head and Neck Cancer Study Design and CMC Development Plan for NDA - Business Wire

Read the Rest...

15 Biotech Companies In Houston To Know – Built In

§ June 19th, 2020 § Filed under Nano Medicine Comments Off on 15 Biotech Companies In Houston To Know – Built In

Houston has played a significant role in boosting the nations biotech industry. While Houston is still a hotspot for energy and oil, the city is steadily becoming a burgeoning life sciences hub. In fact, the city boasted the third fastest-growing biotech community in the nation between 2014 and 2017, according to a CBRE report. Houstons biotech industry is gaining momentum due to an increase in funding as well. According to the Greater Houston Partnership, nearly $180 million in VC funding was allocated to the citys ecosystem of life sciences-related companies in 2019 alone.

Like many startups and tech companies across Houston, the citys life sciences leaders have been tackling some of the worlds most pressing issues. Whether theyre developing oncology drug candidates or advancing genomic medicine through the creation of sequencing technologies, the citys biotech organizations are pulling on decades of research and determination to transform the medical landscape on a global scale. Heres a look at 15 biotech companies in Houston making a major impact on medical research and discovery.

Founded: 2015

Focus: Canine Cancer Treatment

What they do:CAVU Biotherapiesprovides immune-based solutions to treat cancer and autoimmune diseases in dogs. The company offers an immune health monitoring service, which describes a dogs immune system through the use of a blood sample, as well as an autologous prescription product that retrains and expands a dogs T cells to recognize and fight cancer. CAVU Biotherapies ultimate aim is to use its immune-guided medicine to treat horses, cats, andeventually, humans.

Founded: 2006

Focus: Stem Cell Banking + Therapy

What they do: Founded by David Eller and Dr. Stanley Jones, Celltex Therapeutics focuses on developing stem cell therapies for a variety of conditions. The companys stem cell processing and banking methods are designed to ensure the genetic integrity and uniformity of an individuals cells in quantities necessary for therapeutic applications. Using proprietary technology, Celltex Therapeutics enables stem cells to be used for regenerative therapy for conditions like vascular, autoimmune and degenerative diseases.

Founded: 2006

Focus: Cell Therapy

What they do: InGeneron is a clinical stage cell therapy company that specializes in novel, evidence-based regenerative medicine therapies. The companys therapy is designed to repair injured tissue, improve the quality of life for patients and modify the progression of their disease. InGeneron focuses mainly on musculoskeletal indications such as pain management.

Founded: 2006

Focus: Cancer Treatment

What they do: Moleculin Biotech is a pharmaceutical company dedicated to the treatment of highly resistant cancers and viruses. The company develops oncology drug candidates for highly resistant tumors as well as as prodrug to exploit the potential uses of inhibitors of glycolysis. Guided by the aim to provide new hope to cancer patients, Moleculin Biotech focuses on discovering new treatments for acute myeloid leukemia, skin cancer, pancreatic cancer and brain tumors.

Founded: 2001

Focus: Nanomedicine

What they do: Nanospectra Biosciences is spearheading a patient-centric use of nanomedicine for the removal of cancerous tissues. The companys ultra-focal nanoshell technology is designed to thermally destroy solid tumors without damaging adjacent healthy tissue. Nanospectra Biosciences aims to maximize treatment efficacy while minimizing side effects associated with surgery, radiation and traditional focal therapies.

Founded: 2018

Focus: Cell Therapy

What they do: Marker Therapeutics is an immuno-oncology company that focuses on the development of next-generation T cell-based immunotherapies. With the aim of treating hematological malignancies and solid tumor indications, the company uses its own MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells. Marker Therapeutics is also working on developing proprietary DNA expression technology that is intended to improve the cellular immune systems ability to recognize and destroy diseased cells.

Founded: 2008

Focus: 3D Cell Culture

What they do: Nano3D Biosciences is dedicated to the development of 3D cell culture solutions. The companys core technology allows them to levitate or bioprint cells, which results in the formation of cultures that are more easily assembled and handled. Nano3D Biosciences products and services are intended for biomedical research, drug discovery, precision medicine, toxicology and regenerative medicine.

Founded: 2017

Focus: Small Molecule Inhibitors

What they do: Tvardi Therapeutics is a clinical-stage biotech company working on a new class of medicines for cancer, chronic inflammation and fibrosis. The company is focusing on the creation of orally delivered, small molecule inhibitors of STAT3, which is a key regulatory protein positioned at the intersection of many disease pathways. Tvardi Therapeutics is dedicated to delivering safe and effective solutions for use in the treatment of numerous diseases.

Founded: 2011

Focus: Targeted Cancer Therapies

What they do: Salarius Pharmaceuticals focuses on developing targeted therapies to treat various types of cancers. The companys lead candidate, Seclidemstat, is intended to treat Ewing sarcoma, a pediatric and young adult bone cancer that currently lacks targeted therapies. Salarius Pharmaceuticals performs clinical trials for the treatment of other advanced solid tumors including prostate, breast and ovarian cancers.

Founded: 2013

Focus: Genomic Medicine

What they do: Founded by Michael Metzker, RedVault Biosciences develops technologies with the aim of advancing genomic medicine. The company is currently working on a variety of projects including the development of sequencing technologies to determine haplotypes and structural variation in complex genomes. RedVault Biosciences is dedicated to identifying technology needs, creating and testing ideas, and transferring deliverables to production and distribution.

Founded: 2010

Focus: DNA Sequencing

What they do: Avance Biosciences focuses on assay development, assay validation and sample testing using next-generation DNA sequencing and other biological methods. The company offers biologics testing, diagnostic assay validation, GMO genomic testing, gene / cell therapy testing, digital and real-time PCR, microbial testing and more. Avance Biosciences aim is to assist its clients in advancing drug development and genomic research.

Founded: 2008

Focus: Bioremediation

What they do: Bionex Technology develops cost-effective, natural solutions for cleaning oil-polluted soil. The companys Super Microbe spill solution is naturally derived from microbes that digest and convert harmful contaminants on the ground and in soil, therefore lowering flammability, suppressing harmful vapors and creating a safer environment for spill responders. Bionex Technology offers a variety of other bioremediation products such as a customizable degreaser and detergent used for cleaning industrial tools.

Founded: 2016

Focus: Stem Cell Research

What they do: Located in nearby Sugar Land, Hope Biosciences is dedicated to developing stem cell-based therapies that are safe, effective and secure. The companys proprietary technology enables patients to make virtually unlimited and identical stem cells from their own tissue. Hope Biosciences offers stem cell banking solutions for both adults and newborns.

Founded: 2013

Focus: Interventional Cardiology

What they do: Saranas has created technology that enables the early detection and monitoring of bleeding complications associated with vascular access procedures. The companys monitoring system checks changes in the blood vessels electrical resistance before monitoring if bleeding has occurred from an unintentionally injured blood vessel. Saranas aims to allow physicians to mitigate downstream consequences by addressing bleeds before they become complications.

Founded: 1984

Focus: Microbiology

What they do: Microbiology Specialists Inc. specializes in microbiology testing, playing a role in microbial investigations and studies. The company also focuses on infectious disease diagnosis, forensic bacteriology and mycology, medical device testing and infection prevention. Microbiology Specialists Inc. is committed to delivering reliable, accurate and cost-effective microbiological results.

Follow this link:
15 Biotech Companies In Houston To Know - Built In

Read the Rest...

Impact of Covid-19 on Nanotechnology in Drug Delivery Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Microsoft,…

§ June 19th, 2020 § Filed under Nanotech Comments Off on Impact of Covid-19 on Nanotechnology in Drug Delivery Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Microsoft,…

Global Nanotechnology in Drug Delivery Market Overview Global Nanotechnology in Drug Delivery Market presents insights on the current and future industry trends, enabling the readers to identify the products and services, hence driving the revenue growth and profitability. The research report provides a detailed analysis of all the major factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, opportunities, and industry-specific trends. Further, the report cites global certainties and endorsements along with downstream and upstream analysis of leading players.

The novel COVID-19 pandemic has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. This report presented by Garner Insights contains a thorough analysis of the pre and post pandemic market scenarios. This report covers all the recent development and changes recorded during the COVID-19 outbreak.

Understand the influence of COVID-19 on the Nanotechnology in Drug Delivery Market Size with our analysts monitoring the situation across the globe.

Access PDF Sample Copy of the Report, With 30 mins free consultation! Click here@

This Nanotechnology in Drug Delivery market report aims to provide all the participants and the vendors will all the details about growth factors, shortcomings, threats, and the profitable opportunities that the market will present in the near future. The report also features the revenue share, industry size, production volume, and consumption in order to gain insights about the politics to contest for gaining control of a large portion of the market share.

Top Key Players in the Nanotechnology in Drug Delivery Market: Microsoft,Software,IBM,Oracle,PostgreSQL,NCR,Pervasive Software,Tandem,FileMaker,.

Competitive landscape The Nanotechnology in Drug Delivery Industry is severely competitive and fragmented due to the existence of various established players taking part in different marketing strategies to increase their market share. The vendors operating in the market are profiled based on price, quality, brand, product differentiation, and product portfolio. The vendors are turning their focus increasingly on product customization through customer interaction. Nanotechnology in Drug Delivery Market segment by Regions/Countries: United States, Europe, China, Japan, Southeast Asia, India, Central & South America.

To get this report at a profitable rate.:

Major Types of Nanotechnology in Drug Delivery covered are: Targeted Delivery,Drug Package,

Major end-user applications for Nanotechnology in Drug Delivery market: Cancer,Tumor,Other,

Points Covered in The Report:

Reasons for Buying Global Nanotechnology in Drug Delivery Market Report:

Access full Report Description, TOC, Table of Figure, Chart, etc. @ Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.

Contact Us: Kevin Thomas Contact No: +1 513 549 5911 (US) +44 203 318 2846 (UK)

Go here to read the rest:

Impact of Covid-19 on Nanotechnology in Drug Delivery Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Microsoft,...

Read the Rest...

Impact of COVID-19 on Carbon Nanotubes (CNT) Market Potential Growth and Forecast Period 2020-2027 | By Leading Players CNano Technology Limited,…

§ June 19th, 2020 § Filed under Nanotech Comments Off on Impact of COVID-19 on Carbon Nanotubes (CNT) Market Potential Growth and Forecast Period 2020-2027 | By Leading Players CNano Technology Limited,…

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Carbon Nanotubes (CNT) market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Carbon Nanotubes (CNT) Market: Showa Denko, Carbon Solutions, Future Carbon GmbH, and Continental Carbon Nanotechnologies Inc.

We Do Offer Sample of this report. Kindly go through the follow information in order to access sample copy.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report:

The report begins with a brief introduction and market overview of the Carbon Nanotubes (CNT) industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: Showa Denko, Carbon Solutions, Future Carbon GmbH, and Continental Carbon Nanotechnologies Inc.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report:

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Carbon Nanotubes (CNT)

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Carbon Nanotubes (CNT) market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Carbon Nanotubes (CNT) market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Carbon Nanotubes (CNT) market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Carbon Nanotubes (CNT) market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Carbon Nanotubes (CNT) market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report:

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: Coherent Market Insights, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: Phone: US +1-206-701-6702/UK +44-020 8133 4027

Continue reading here:

Impact of COVID-19 on Carbon Nanotubes (CNT) Market Potential Growth and Forecast Period 2020-2027 | By Leading Players CNano Technology Limited,...

Read the Rest...

« Older Entries Newer Entries »

Page 13«..10..12131415..2030..»